Predictions
Grand City Properties S.A.
Start price
Target price
Perf. (%)
€10.64
16.04.24
16.04.24
-
16.04.25
16.04.25
8.08%
21.05.24
21.05.24
CompuGroup Medical SE & Co. KGaA
Start price
Target price
Perf. (%)
€30.48
10.04.24
10.04.24
-
10.04.25
10.04.25
-6.30%
21.05.24
21.05.24
Fielmann AG
Start price
Target price
Perf. (%)
€42.55
01.04.24
01.04.24
€44.00
01.04.25
01.04.25
5.52%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
CompuGroup Medical SE & Co. KGaA
Start price
Target price
Perf. (%)
€27.02
22.03.24
22.03.24
-
22.03.25
22.03.25
5.70%
21.05.24
21.05.24
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€125.90
12.03.24
12.03.24
-
12.03.25
12.03.25
-22.48%
21.05.24
21.05.24
Probably not worthwhile Investment
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€144.95
10.02.24
10.02.24
€147.00
10.02.25
10.02.25
5.07%
29.03.24
29.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€141.75
07.02.24
07.02.24
€144.00
07.02.25
07.02.25
2.26%
10.02.24
10.02.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€140.35
06.02.24
06.02.24
€142.00
06.02.25
06.02.25
1.00%
07.02.24
07.02.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Südzucker AG
Start price
Target price
Perf. (%)
€14.26
10.01.24
10.01.24
€17.00
10.01.25
10.01.25
-8.49%
20.01.24
20.01.24
Higher EBIT margin than peer group
Revenue growth >5% per year expected
Future proof or reliable business model
Top 10 in its market
Südzucker AG
Start price
Target price
Perf. (%)
€14.40
03.01.24
03.01.24
€19.00
03.01.25
03.01.25
-0.97%
06.01.24
06.01.24
Higher EBIT margin than peer group
Revenue growth >5% per year expected
Future proof or reliable business model
Top 10 in its market
MorphoSys AG
Start price
Target price
Perf. (%)
€17.06
26.11.23
26.11.23
-
26.11.24
26.11.24
57.74%
09.12.23
09.12.23
Could be worthwhile Investment >10% per year